Mankind Pharma Sees Margin Expansion, Chronic Segment Gains in Q3FY26
Mankind Pharma announced its consolidated financial results for the third quarter and nine months ended December 31, 2025, reporting steady growth driven by improved performance in its domestic pharmaceutical business and consolidation of its BSV portfolio.
ACG | 04/02/2026 | By Darshana | 136
ACG Launches DryPod for Moisture-Sensitive Pharmaceutical Blisters
DryPod by ACG marks an advancement for pharmaceutical manufacturers who have long grappled with limited availability, rigid technologies, and compatibility issues within existing desiccant cold-form solutions.
ACG | 21/11/2025 | By Dineshwori | 559
ACG Announces USD 200 Million Investment for Empty-Capsule Manufacturing In the US
ACG has announced a USD 200 million phased investment to establish its first empty-capsule manufacturing operations in the United States.
ACG | 21/10/2025 | By Dineshwori | 301
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy